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Abstract.  Brefeldin A  (BFA)  was shown in earlier 
studies of numerous cell types to inhibit  secretion,  in- 
duce enzymes of the Golgi stacks to redistribute into 
the ER, and to cause the Golgi cisternae to disappear. 
Here, we demonstrate that the PtKt  line of rat kan- 
garoo kidney cells is resistant to BFA. The drug did 
not disrupt the morphology of the Golgi complex in 
PtKt cells, as judged by immunofluorescence using an- 
tibodies to 58- (58K) and  l l0-kD  (B-COP) Golgi pro- 
teins,  and by fluorescence microscopy of live cells la- 
beled with C6-NBD-ceramide.  In addition,  BFA did 
not inhibit protein secretion,  not alter the kinetics or 
extent of glycosylation of the vesicular stomatitis virus 
(VSV) glycoprotein (G-protein)  in VSV-infected PtKt 
cells.  To explore the mechanism  of resistance to BFA, 
PtKt cells were fused with BFA-sensitive CV-1 cells 
that had been infected with a  recombinant SV-40  strain 
containing  the gene for VSV G-protein and,  at various 
times following fusion,  the cultures were exposed to 
BFA.  Shortly after cell fusion, heterokaryons con- 
tained one Golgi complex associated with each nu- 
cleus.  Golgi membranes derived from CV-1 cells were 
sensitive to BFA, whereas those of PtKt origin were 
BFA resistant.  A  few hours after fusion, most hetero- 
karyons contained a  single,  large Golgi apparatus that 
was resistant to BFA and contained CV-1 galac- 
tosyltransferase.  In unfused cells that had been perfo- 
rated using nitrocellulose filters,  retention of/3-COP 
on the Golgi was optimal in the presence of cytosol, 
ATP, and GTE  In perforated cell models of the BFA- 
sensitive MA104 line,  BFA caused 3-COP to be 
released from the Golgi complex in the presence of 
nucleotides, and either MA104 or PtK~ cytosol. In 
contrast,  when perforated PtKl cells were incubated 
with BFA, nucleotides, and cytosol from either cell 
type, ~-COP remained bound to the Golgi complex. 
We conclude that PtKl  cells contain a  nondiffusible 
factor, which is located on or very close to the Golgi 
complex, and confers a  dominant  resistance to BFA.  It 
is possible that this factor is homologous to the target 
of BFA in cells that are sensitive to the drug. 
T  rIE Golgi apparatus comprises a series of  membranous 
compartments  in which proteins  are modified post- 
translationally  and sorted so that each is targeted to an 
appropriate  cellular  membrane.  To fulfill  these tasks,  the 
Golgi complex is divided into several structurally  and func- 
tionally distinct regions through which proteins successively 
pass:  the cis-,  medial-,  and trans-Golgi  cisternae,  and the 
trans-Golgi  network (Farquhar,  1985; Griffiths and Simons, 
1986). Maintaining  the structural  integrity of  the Golgi com- 
plex and  its various  compartments  represents  a significant 
challenge  for the cell because large quantities of protein and 
lipid regularly pass between the Golgi complex and  other 
membranous organelles.  For example,  proteins destined for 
processing in the Golgi network are exported from the ER 
along with more numerous resident ER proteins.  This pro- 
cess occurs by a mechanism  that  concentrates the former 
proteins 5-10-fold in the Golgi complex, while efficiently 
returning  the ER proteins to their normal place of residence 
(Green et al., 1981; Griffiths et al., 1984; Warren 1987; Pel- 
ham,  1989). An equally important feature of this process is 
that  proteins  which  perform their  functions  in  the  Golgi 
complex are selectively  retained within the Golgi complex. 
Thus,  the exchange of membrane components between the 
ER and the Golgi membrane is opposed by at least two con- 
centration  gradients,  one favoring escape of abundant  ER 
proteins into Golgi membranes that lack them,  and another 
favoring  absorption  of Golgi  membrane  constituents  into 
the ER. 
Evidently,  the cell uses multiple  sorting steps to prevent 
the net transfer  of ER proteins to the Golgi membrane and 
of Golgi proteins to the ER. One of these sorting steps is ac- 
complished during  the formation  of transport vesicles that 
emanate from the ER (Palade,  1975; Bergmann  and Singer, 
1983), while another  occurs in an immunologically  distinct 
compartment juxtaposed to the Golgi complex (Seraste and 
Kuismanen,  1984; Tooze et al., 1984; Warren,  1987; Schwei- 
zer et al., 1988; Pelham,  1989). This intermediate  compart- 
ment has been proposed to segregate "escaped" ER proteins 
from proteins which proceed through the secretory pathway. 
As a result,  component proteins of the ER can be recycled 
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proteins that require further posttranslational modifications 
can be transported to cis-Golgi cisternae. It seems likely that 
these protein sorting events are coupled to the formation of 
vesicles derived from the intermediate compartment, and 
that some of the vesicles fuse selectively with the ER, while 
others merge specifically with the cis-Golgi membrane (re- 
viewed in Pelham,  1989).  In principle, such a mechanism 
could prevent the flow of Golgi membranes into the inter- 
mediate compartment, and by extension, into the ER. 
Further insight into the mechanism for preventing Golgi 
proteins from escaping into the ER has been gained recently 
through studies of the fungal metabolite, brefeldin A (BFA)  t. 
Treatment of cultured cells with BFA was found to cause 
resident Golgi proteins to redistribute into the ER by a mech- 
anism that requires energy and intact microtubules (Lippin- 
cott-Schwartz et al.,  1990).  Moreover,  the application of 
BFA to cultured cells has provided evidence that the pathway 
for membrane flow between the ER and Golgi membrane 
contains the  aforementioned ER recycling arm,  which is 
otherwise  difficult to  detect  (Lippincott-Schwartz  et  al., 
1990).  Based on these and related findings (Fujiwara et al., 
1988; Doms et al., 1989; Ulmer and Palade, 1989; Lippin- 
cott-Schwartz et al.,  1990),  it has been proposed that BFA 
acts through a specific molecular target and directly inhibits 
only one aspect of membrane traffic (Lippincott-Schwartz et 
al.,  1990).  If BFA does, indeed, inactivate a specific Golgi 
target that plays a critical role in maintaining the separate 
identity of Golgi membranes, then BFA-treated cells may be 
as useful for understanding the control of intracellular pro- 
tein traffic in animal cells as mutant strains have been for un- 
ravelling the secretory pathway in yeast. As of now, however, 
the hypothesis that BFA acts directly on a single intracellular 
target and exerts a limited number of specific effects has been 
supported mainly by the observations that BFA does not alter 
cellular ATP levels,  protein synthesis, or endocytosis, and 
affects cells at submicromolar concentrations (Misumi et al., 
1986;  Lippincott-Schwartz et al.,  1990). 
The  identification of "mutant" cells  containing a  Golgi 
complex resistant to BFA could provide a means for iden- 
tifying the hypothetical BFA  target,  and  for  determining 
whether the membrane redistribution observed in cells treat- 
ed with the drug depends upon the imperfect operation of 
pathways normally active in the cell or upon novel pathways 
that are induced by BFA. In this report, we present evidence 
that the Golgi apparatus in the rat kangaroo kidney cell line, 
PtKI, is unaffected structurally or functionally by BFA. The 
resistance of PtK~ cells to BFA cannot be explained by an 
inability of  the drug to enter the ceils, or by the sequestration 
or inactivation of BFA once it gains access to the cytoplasm. 
Instead, in PtKt cells the Golgi complex itself, or a com- 
partment directly adjacent to the Golgi apparatus appears to 
contain a dominant, nondiffusible factor that confers resis- 
tance to BFA. This factor may represent a BFA-insensitive 
version of the molecule which serves as the target for BFA 
in other cell types. 
1. Abbreviations used in this paper: BFA, brefeldin A; endo H, endoglycosi- 
dase H; G Protein, glycoprotein; Gai T, galactosyltransferase; VSV, vesicu- 
lar stomatitis virus. 
Materials and Methods 
Biochemical Supplies and Viral Reagents 
BFA was purchased from Epicentre Technologies (Madison, Wl) and was 
dissolved at 10 mg/ml (36 raM) in DMSO or ethanol. C6-NBD-ceramide 
was purchased from Molecular Probes (Eugene, OR) and was dissolved at 
5 mM in ethanol. Endoglycosidase H (endo H), ATE GTP, creatine phos- 
phate, and rabbit creatine phosphokinase were purchased from Boehringer 
Mannheim Biochemicais (Indianapolis, IN). All other chemicals and bio- 
chemicals were from Sigma Chemical Co. (St. Louis, MO). Vesicular sto- 
matifis virus (VSV) was propagated in MDCK cells (Roth and Compans, 
1981). Recombinant SV-40 virus carrying the gene for VSV G protein was 
prepared as described previously (Doyle et ai.,  1985). 
Cell Culture 
PtK1 cells (American Type Culture Collection [ATCC];  Rockville, MD) 
were grown in MEM containing nonessential amino acids (Sigma Chemical 
Co.),  and  fortified with  sodium pyruvate  to  1  mM  and  defined,  sup- 
plemented bovine calf serum (HyClone Laboratories, Logan, UT) to 10% 
final concentration. CV-1 (African green monkey kidney) cells (ATCC) and 
MA104 (rhesus monkey kidney) cells (Roth et al.,  1987)  were grown in 
DME (Gibco Laboratories, Grand Island, NY) supplemented with Serum 
Plus (Hazleton Research Products Inc., Lenexa, KS) to 10% final concen- 
trafion. Co-cultures of PtK1 and CV-1 cells were maintained in PtKt me- 
dium. Gentamycin (Sigma Chemical Co.) was included in all culture media 
at a final concentration of 50 ~g/ml. 
lmmunofluorescence Microscopy 
The following antibodies were used: polyclonai rabbit anti-VSV glycopro- 
tein  (G  protein;  [Roth  and Compans,  1981]);  monoclonai mouse anti- 
VSV G protein (clone I1; Le Franfois and Lyles, 1982);  polyclonal rabbit 
anti-human milk gaiactosyltransferase (GaiT;  Berger et al., 1987);  mono- 
clonai mouse anti-58-kD protein (Bloom and Brashear, 1989);  monoclonai 
mouse  anti-/~-COP  (ll0-kD  protein;  Alan  and  Kreis,  1986);  affinity 
purified  second antibodies,  including  FITC-labeled  and  TRITC-labeled 
goat anti-rabbit IgG, and Texas red-labeled goat anti-mouse IgG (Southern 
Biotechnologies, Birmingham, AL). For immunofluorescence, all antibod- 
ies  were diluted into  PBS  containing  1%  BSA.  Anti-58K was  used  in 
purified form at 10/~g/ml. Other primary antibodies were in the form of 
polyclonal antisera and monoclonal ascites fluids. These were diluted 1:200, 
except for anti-Gai T, which was used at a 1:50 dilution. Fluorescent second 
antibodies were used at 5/~g/mi. 
Cells growing on No. 1 thickness coverslips were washed twice with PBS 
containing  1 mM MgC12 and 0.1  mM CaCI2,  and then were fixed with 
3.7% formaldehyde in 0.1 M phosphate buffer at pH 7.2 for 10 rain at room 
temperature. After fixation, the cells were rinsed once with DME and in- 
cubated with DME for 10 additional min to inactivate free aldehyde groups. 
The cells were then permeabilized by a 5-rain incubation in methanol at 
-20"C, after which they were subjected to the following successive incuba- 
tions at room temperature: (a) 30 min in 1% BSA in PBS; (b) 45 rain (for 
double labeling) or 1 h (for single labeling) in primary antibodies; (c) 3  x 
5' each in 1% BSA/PBS; (d) 1 h in fluorescently labeled second antibodies; 
(e) 3  x  10' in 1% BSA/PBS. The coverslips were then mounted onto glass 
slides using Mowiol (Polysciences Inc., Warrington, PA). The specimens 
were viewed on a Zeiss Axiophot microscope using a 63 x  planapo objec- 
five, and photographed  on TMAX 3,200 film (Eastman Kodak Corp.; Roch- 
ester, NY), which was processed with TMAX developer for an effective  film 
speed of E1 800. 
Vital Staining of Cells with C6-NBD-ceramide 
Immediately before use, C6-NBD-ceramide was added to a final concen- 
tration of 5/~M to a solution of DME supplemented with defatted BSA to 
0.34 mg/ml. All subsequent steps were performed at 37°C. Cells growing on 
coverslips were washed twice with DME to remove serum, and were then 
incubated with the C6-NBD-ceramide solution for 20 min. The labeling 
solution was removed after this incubation, and the cells were then washed 
with DME and incubated for 1 h with DME containing 10% calf serum. 
At the end of the hour, most of the fluorescent C6-N-BD-ceramide  had ac- 
cumulated in the Golgi complex, and the ceils were then treated with BFA. 
After exposure of cells to BFA for the indicated lengths of time, the cover- 
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scribed above for immunofluorescence. 
A nalysis of Glycoprotein Processing 
CV-1 or PtKl cells growing in 35-mm-diam culture dishes were infected 
with VSV for 30 min on ice, washed free of unbound virus, and incubated 
at 37°C for 3.5 h. The cells were then incubated for 30 rain in the presence 
or absence of 36 #M (10/~g/ml) BFA in 0.5-ml per dish of DME lacking 
methionine and cysteine, and supplemented with dialyzed calf serum at 2 % 
final  concentration.  Next,  the cells were labeled for  10  min  with 35S- 
methionine and cysteine by direct addition of 50 #Ci per dish of Tran35S 
label (ICN Radiochemicals, Irvine, CA). Radiolabeling was terminated by 
adding a  104-fold molar excess of nonradioactive methionine and cysteine 
directly to the medium. After the indicated times of  chase, cell lysates were 
prepared and immunoprecipitated with rabbit anti-VSV G protein (Lazaro- 
vits et al.,  1990).  The immunoprecipitates were digested with endo H and 
then analyzed by SDS-PAGE fluorography (Lazarovits et al., 1990).  When 
BFA was used, it remained present throughout the entire pulse and chase 
period. 
Protein Secretion Assays 
CV-1 and etKl cells grown in six-well culture dishes were incubated for 
30 rain at 37°C in the absence of BFA, or in the presence of 1.8 or 36/~M 
(0.5 or 10 tLg/ml) BFA. The cells were then pulse labeled for 10 rain with 
20/~Ci/well of 35S-methionine  or 3H-leucine at 37°C, and chased for 1 h 
with excess, unlabeled methionine or leucine at 37"C or on ice. When BFA 
was used, it was present throughout the pulse and chase periods. After the 
chase, tissue culture medium was collected from each well and centrifuged 
for 10 min at 16,500 g in an Eppendorf microcentrifuge (Brinkman Instru- 
ments Inc., Westbury, NY). TCA-precipitable radioactivity was then mea- 
sured in 75-td aliquots of each sample by liquid scintillation counting. The 
cpm in samples that had been chased on ice were defined as background. 
Levels of protein secretion were determined for each experimental condi- 
tion by subtracting the background cpm from the cpm in samples that had 
been chased at 37°C, but were otherwise identical. 
Formation of Heterokaryons from PtK1 and CV-1 Cells 
Day 0: PtKt cells were plated onto glass coverslips in six- or 24-well cul- 
ture dishes at densities which would ensure that the cells would reach "-50 % 
confluency on day 5.  Day 3:CV-1  cells at "o70% confluency were tryp- 
sinized, infected in suspension with the recombinant SV-40 virus encoding 
the VSV G protein gene, and replated into new culture dishes at the same 
density. Day 4: the SV-40 vector-infected CV-1 cells were trypsinized and 
then plated onto the PtK~ ceils at sufficient density to make the CV-1 cells 
"¢70%  confluent the next day. Because SV-40 infection is limited to cells 
of a few simian species (Tooze,  1980),  no PtK1 cells were infected by the 
SV-40 vector during co-culturing with CV-1 cells. Day 5: fusion was initi- 
ated 36-40 h after infection of CV-1 cells with the vector; coverslips were 
washed at room temperature twice briefly with MEM, twice with fusion 
buffer (100 mM NaC1, 50 mM MES, pH 5.5) for a total of 3 min, and twice 
with MEM buffered with 10 mM Hepes at pH 7.4.  The cells were then 
returned to 37°C in the standard PtKI medium (see above) with or with- 
out BFA. 
Perforated Cell Models 
Type HA, 0.45  ~m pore size nitrocellulose filters (Millipore Continental 
Water Systems, Bedford, MA) were used to perforate cell monolayers by 
a modification of the wet cleave method (Simons and Verta,  1987; Brands 
and Feltkamp,  1988).  Before the perforation step, PtK1 and MA104 cells 
were cultured on glass coverslips for at least 3 and 4 d, respectively. To per- 
forate cells, each coverslip was processed at room temperature by the fol- 
lowing sequential steps: (a) immerse in DME for 10 s; (b) immerse in PBS 
for 10 s; (c) remove excess moisture by touching a corner of the coverslip 
with filter paper; (d) invert onto prewetted nitrocellulose for 2 min at room 
temperature; (e) gently peel the coverslip off  of the nitrocellulose; (f) incu- 
bate for 30 sec in transport buffer (78 mM KC1, 50 mM Hepes, pH 7.0, 2.5 
mM MgCI2,  10 mM EGTA, 8.37  mM CaC12,  1 t~M DTT);  and (g) place 
in 24-well plates. Each piece of nitrocellulose could accommodate a set of 
16 coverslips, allowing uniform perforation conditions to be achieved for 
each set. 
After  the  perforation  protocol,  permeabilized cell  models  were  in- 
cubated for 30 min at 37°C in transport buffer supplemented with 1 mM 
ATP, 1 mM GTP, 2 mM creatine phosphate, 7 IU/ml rabbit muscle creatine 
phosphokinase and cytosol. The cytosol was prepared from PtKl or MA104 
cells by the procedure described in Beckers et al. (1987),  and was used at 
a final concentration of  0.5-2.0 mg/ml. BFA was included in some of these 
incubations at a final concentration of 36 #M (10 #g/ml). After the incuba- 
tions, the cells were fixed and processed for immunofluorescence as de- 
scribed earlier for intact cells, but the methanol permeabilization step was 
omitted. 
Results 
The Golgi Complex Remains Morphologically Intact 
in PtKI Cells Exposed to BFA 
Several markers were used to examine the morphological re- 
sponse of the PtK~ Golgi complex to various concentrations 
of BFA. CV-1 cells, which display a rapid and complete sen- 
sitivity to BFA, were used as a positive control for these ex- 
periments.  Fig.  1 presents micrographs of PtK1 and CV-1 
cells that were cultured in the presence or absence of BFA, 
and  labeled  for immunofluorescence with mAbs  directed 
against two proteins associated with the Golgi apparatus. 
One of  these is a 58 kD, cytoplasmicaUy  oriented, peripheral 
membrane component of the Golgi apparatus. This protein, 
known as "58K" binds directly to microtubules and has been 
proposed to be involved in anchoring the Golgi apparatus to 
microtubules in vivo (Bloom and Brashear, 1989). The other 
protein, a  ll0-kD species (Alan and Kreis,  1986),  was re- 
cently shown to dissociate from the Golgi apparatus in cul- 
tured cells within 30 s of BFA exposure (Donaldson et al., 
1990),  and to bear  significant homology to  the clathrin- 
associated protein,  5-adaptin  (Duden et al.,  1991). Now 
called "/3-COP" this 110-kD protein is a major subunit of the 
nonclathrin coat which envelopes intra-Golgi transport vesi- 
cles (Duden et al.,  1991; Serafini et al.,  1991). 
In the absence of BFA, the Golgi apparatus was clearly la- 
beled  in both  PtK~ and  CV-1 cells  with anti-/~-COP  and 
anti-58K (Fig. 1, A, C, E, and G). Faint, diffuse cytoplasmic 
staining was also evident occasionally with both antibodies, 
and probably represented soluble pools of 58K and/~-COP. 
After CV-1 cells were exposed for 30 min to  1.8/~M (0.5 
/zg/ml) BFA, the localization of/~-COP and 58K was altered, 
as both proteins appeared to be dispersely distributed through- 
out the cytoplasm (B and D). Recent evidence suggests that 
BFA exerts distinct effects on these two proteins, causing a 
redistribution of 58K into the ER and solubilization of/~-COP 
(Donaldson et al.,  1990).  Neither of these effects were ob- 
served in BFA-treated PtK~ cells.  The Golgi apparatus in 
this cell line was prominently labeled by both anti-58K and 
anti-/3-COP  after BFA  incubations as  extreme  as  71  /~M 
(20 #g/ml) for 3 h  (F and H) or  178 mM (50/~g/ml)  for 
1 h  (not shown). 
To determine whether the redistribution of 58K and E-COP 
that was induced in CV-1 cells by BFA was also accompanied 
by dispersal of nonproteinaceous components of the Golgi 
complex, living cells were stained with C6-NBD-ceramide. 
This fluorescent sphingolipid is initially incorporated in the 
plasma membrane, mitochondria and ER, after which fluo- 
rescent metabolites of the compound accumulate predomi- 
nantly  in trans-Golgi stacks  (Lipsky and  Pagano,  1985; 
Pagano et al.,  1989).  PtK~ or CV-1 cells that had been la- 
Ktistakis et al.  The PtK1 Cell Golgi Is Resistant to Brefeldin A  1011 Figure 1. Immunofluorescence  evidence for the resistance of PtK~ cells to BFA. PtKI and BFA-sensitive CV-1 cells were treated with BFA, 
and stained for immunofluorescence  with anti-~-COP or anti-58K, marker antibodies for the Golgi apparatus.  BFA exposures  were 30 
rain at 1.8/~M (0.5/~g/ml)  BFA for CV-1 cells, and 3 h at 71 ~M (20/zg/ml) for PtK~ cells.  Note that intact Golgi complexes remained 
in PtK~ cells,  but not in CV-1 cells,  after exposure  to BFA. Bar,  10 #m. 
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treated and BFA-treated live cells labeled with C6-NBD- 
ceramide.  Shown here are fluorescence micrographs  of 
live cells that had been labeled with the vital Golgi stain, 
C6-NBD-ceramide, and were subsequently cultured  for 
30 min in the absence or presence of 36 t~M (10/~g/ml) 
BFA.  Prominent  Golgi  complexes  remained  in  PtK] 
cells, but not in CV-I cells, that were treated with BFA. 
Bar, 5 #m. 
beled with C6-NBD-ceramide were incubated for 30 min in 
the presence or absence of 36 #M (10/zg/ml) BFA.  Then, 
the unfixed cells were examined and photographed using a 
light microscope and epifluorescence illumination.  The re- 
suits obtained using this approach were comparable to those 
acquired by immunofluorescence: the CV-1 Golgi complex 
nearly disappeared when BFA was present, whereas staining 
of the PtK~ Golgi complex remained unaffected by the drug 
(Fig.  2). 
The Golgi Apparatus in PtKz Cells Is Not Impaired 
Functionally by BFA 
Two of the most conspicuous general effects of BFA in cells 
that are sensitive to the drug are the disappearance of the 
Golgi complex itself (Fujiwara et al.,  1988;  Doms et al., 
1989; Lippincott-Schwartz et al.,  1989), and a profound in- 
hibition of functions normally served by the Golgi complex. 
Included within the latter category are reductions in the rates 
of secretion, and of Golgi-dependent, posttranslational mod- 
ification of newly synthesized proteins (Misumi et al., 1986; 
Doms et al.,  1989;  Lippincott-Schwartz et al.,  1989).  The 
results described in the previous section indicated that the 
Golgi  apparatus  remains  morphologically  intact  in  PtKt 
cells exposed to BFA. To assess whether the Golgi apparatus 
is also unperturbed functionally by BFA in PtK~ cells, effects 
of the drug on both secretion and the processing of protein- 
bound oligosaccharides were monitored. 
Secretion was investigated  by exposing PtK~ and CV-1 cells 
to radiolabeled amino acids for 10 min, chasing for 60 min 
with unlabeled amino acids, and then measuring TCA-pre- 
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Figure 3.  Secretion is not inhibited  in PtK1 cells 
treated with BFA. Control and BFA-treated  cultures 
of PtK] and CV-1 cells were pulse labeled for 10 
min at 37°C  with 3H-leucine or 35S-methionine, 
and then chased with unlabeled amino acids for 1 h 
at 37 ° C or on ice. When BFA was used it was pres- 
ent throughout the entire pulse and chase period. 
After  the  chase,  TCA-precipitable  counts  were 
measured in 75-/zl aliquots of  tissue culture media, 
duplicate samples of which were measured in all 
cases. Levels of  protein secretion were determined 
by subtracting  the  TCA-precipitable counts pro- 
duced  by cultures  that  had been chased  on ice 
(background  counts) from the counts yielded  by 
cultures that had been chased at 37°C, but were 
otherwise identical. Shown here are the normalized 
results  from three  sets  of experiments,  two  of 
which used aH-leucine and the other of which was performed using 35S-methionine. Percent secretion refers to counts secreted by cells 
cultured in the presence of 1.8 or 36/zM (0.5 or 10/zg/ml) BFA compared to counts secreted by control cells. In 75-#1 aliquots of tissue 
culture medium,  control CV-I ceils typically yielded '~25,000 cpm of background-corrected,  secreted protein when 3SS-methionine was 
used, and ",d,000 cpm with 3H-leucine. For control PtKt cells, the values were ,~12,000 cpm with 3~S and ,~400 cpm with 3H. As is evi- 
dent in the graph shown here, BFA inhibited secretion in CV-1 cells by '~80-90%, but the drug did not suppress secretion in PtK1 ceils. 
Ktistakis et al. The PtK1 Cell Golgi Is Resistant to Brefeldin A  1013 Figure 4.  BFA does not inhibit processing of asparagine-linked oligosaccharides in PtK~ cells. CV-1 and PtK~ cells were infected with 
VSV, pulse labeled with 35S-labeled methionine and cysteine, and chased with an excess of unlabeled amino acids. After each chase 
period,  the cells were lysed and VSV G protein was immunoprecipitated and digested with endo H. When present, BFA was added to 
36 ttM (10 #g/ml) 30 min before the 35S pulse began, and remained in the medium throughout the entire pulse and chase. Shown here 
are fluorographs of two SDS-polyacrylamide gels on which several such samples were analyzed. Note that in the absence of BFA and 
after a 15-min chase, a portion of  the VSV G protein in CV-1 cells resisted digestion by endo H, and that all VSV G protein gained resistance 
by 90 min of chase. When BFA was present, endo H resistance was not detected by 90 min of chase. In contrast, the VSV G protein in 
PtK~ cells acquired partial and complete resistance to endo H by 15 and 90 min of chase, respectively, in either the absence or presence 
of BFA. This indicated that in PtK~ cells BFA failed to inhibit Golgi-dependent conversion of the VSV G protein from a high mannose 
to a complex carbohydrate form. The numbers at the bottom of this figure refer to gel lanes, as mentioned in the text. 
used, it was present throughout the pulse and chase periods 
(see Materials and Methods for further details).  As  illus- 
trated in Fig. 3, the levels of protein secreted by CV-1 cells 
grown in the presence of 1.8 (0.5 #g/ml) or 36 #M (10 #g/ml) 
BFA were ,o20 and 10%, respectively, of the level that was 
secreted by drug-free CV-1 cells. In contrast, PtKl cells that 
had been treated with either 1.8 #M (0.5  #g/ml) or 36 #M 
(10/xg/ml) BFA secreted levels of protein that were virtually 
identical to those released into the medium by PtK,  cells 
grown in the absence of the drug. These data firmly indicate 
that BFA does not inhibit secretion in PtKt cells. 
To determine the effects of BFA on Golgi-dependent pro- 
tein processing,  we assayed for conversion of asparagine- 
linked oligosaccharides from high rnannose to complex forms. 
This was accomplished by infecting PtK~ cells with VSV, 
and monitoring the susceptibility of the VSV-encoded trans- 
membrane G  protein to digestion by endo H.  The loss of 
endo H sensitivity  marks the maturation of asparagine-linked 
oligosaccharides to complex forms by a process that occurs 
within the medial Golgi stacks (reviewed in Kornfeld and 
Kornfeld,  1985).  Previously  reported  experiments  using 
CHO cells had demonstrated that BFA caused a 45-90 min 
delay in the acquisition of endo H-resistant oligosaccharides 
by the VSV G protein, and that redistribution of Golgi en- 
zymes to the ER, rather than movement of substrate to the 
Golgi apparatus, led to the eventual processing of the VSV 
G protein (Doms et al.,  1989). In the present case, parallel 
cultures of PtKt and CV-1 cells were infected with VSV and 
pulsed  with  3~S-labeled amino  acids.  For each  cell  type, 
samples were incubated in both the presence and absence of 
BFA throughout a constant radiolabeling period and a vari- 
able chase interval. At the end of each chase interval, VSV 
G  protein was immunoprecipitated, digested with endo H 
and analyzed by SDS-PAGE and fluorography. As illustrated 
in Fig. 4, the VSV G protein produced in both cell types in 
the absence of BFA acquired partial resistance to endo H by 
15 rain of chase and was fully resistant after a 90-min chase 
(lanes 4 and 6). A time-dependent, progressive increase in 
endo H resistance was observed at intermediate time points, 
and was  indistinguishable for the two cell types (data not 
shown). However, in the presence of 36/zM (10 #g/ml) BFA, 
a dramatic difference between the two cell types was noted. 
In PtK~ cells, the VSV G protein produced under these con- 
ditions acquired resistance to endo H with kinetics identical 
to the untreated cells (lanes 10 and 12).  In contrast, by 90 
min of  chase the VSV G protein produced in BFA-treated CV-1 
cells was still totally sensitive to endo H  (lane 12).  As ex- 
pected, some resistance to endo H was seen in the CV-1 cells 
at later times of chase (data not shown). 
To provide a visual image of the Golgi complex in VSV- 
infected PtK~ cells,  cultures were treated with 36 #M  (10 
#g/ml) BFA for 30 min beginning 3.5 h after initial exposure 
to the virus, and were then analyzed by immunofluorescence 
using antibodies to the VSV G protein and to 58K. In agree- 
ment with our previous observations (Figs.  1 and 2), bright 
staining of a morphologically intact Golgi apparatus was ob- 
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mented earlier,  within the  limits  of detectability in  PtKt 
cells, BFA failed to alter Golgi morphology (Fig. 1 and 2), 
inhibit secretion (Fig.  3) or delay the conversion of newly 
synthesized asparagine-linked oligosaccharides from high 
mannose to complex forms (Fig. 4). Thus, in the presence 
of BFA,  the  Golgi apparatus  in  PtKt  cells  remains both 
structurally and functionally intact. 
Heterokaryons Formed by the Fusion of PtK, 
and CV-1 Cells 
Several mechanisms could have accounted for the resistance 
of the PtKt Golgi to BFA. For example, the cells may have 
failed to import BFA, they might have actively exported BFA 
before the drug exerted its effects, or they could have lowered 
the concentration of BFA in the cytoplasm by sequestering 
or degrading it.  Alternatively, PtK~ cells may have been 
resistant to BFA by one of several mechanisms that could be 
useful for investigating the molecular basis for the effects of 
the drug. For instance, perhaps PtKI cells lacked the target 
for BFA, possessed a BFA-insensitive  version of the target, 
or contained a factor that somehow interfered with the action 
of BFA. To attempt to distinguish among these possibilities, 
PtK~ cells were fused to CV-1 cells and the resulting hetero- 
karyons were tested for resistance to BFA.  The CV-1 cells 
used in these experiments were infected with a recombinant 
SV-40 vector containing the gene for the VSV G  protein, 
which was  known from earlier studies to act as a  potent 
cell-cell fusogen below pH 6.0 (White et al., 1981; Rothman 
et al.,  1984). 
The initial fusion experiments, which are described in this 
section,  were  aimed  at  quantitatively characterizing  the 
composition of heterokaryons and the efficiency of their for- 
mation. To that end, we relied upon the use of fluorescent 
markers for each of the two cell types. Before fusion, the 
PtK~ cells were cultured in the presence of 10 mg/ml FITC- 
dextran (average mol mt, 40,000)  for 4 h, during which time 
the fluorescent compound entered the cells by fluid-phase 
endocytosis and became entrapped in lysosomes. The PtK~ 
cells were then chased in the absence of FITC-dextran for 
24 h, during which time the lysosomes containing FITC- 
dextran collected in a  perinuclear region.  The SV-40-in- 
fected CV-1 cells were then added to the culture and allowed 
to attach overnight. At the end of this incubation period, the 
fusogenic pH 5.5 wash was administered to some cultures, 
but not to others, and the cultures were incubated for several 
more minutes. The cells were then fixed with formaldehyde 
without being permeabilized, incubated with a rabbit poly- 
clonal antibody to the VSV G protein followed by a Texas 
red-labeled second antibody, and then examined by fluores- 
cence microscopy. 
In the absence of  the pH 5.5 wash, few multinucleated cells 
were observed. Within the mononucleate population, PtK~ 
cells were unambiguously identified by their bright, perinu- 
clear lysosomes visible in the FITC channel of the micro- 
scope, while CV-1 cells were clearly recognizable by their 
plasma membrane fluorescence in  the  Texas  red channel 
(Fig. 5, D and F). When the pH 5.5 wash was omitted, ceils 
exhibiting fluorescence in both the FITC and Texas red chan- 
nels were extremely rare,  having represented <2 % of the 
multinucleate cell population (Table I). Under those condi- 
tions, therefore, most of the multinucleate cells represented 
polyploid cells that are normally found at low frequency in 
PtKt and CV-1 cultures. 
In cultures that had been exposed to the fusogenic pH 5.5 
wash, we observed four types of cells: unfused CV-1 cells, 
unfused PtK~ cells, CV-1 polykaryons, and heterokaryons. 
Unfused cells were positive in either, but not both channels 
of the fluorescence microscope.  Fused cells were readily 
identified by their multiple nuclei, and both the polykaryons 
and heterokaryons were stained with Texas red as a result of 
having expressed VSV G protein. Approximately 20% of the 
multinucleated cells exhibited fluorescence in both the FITC 
and Texas red channels, and were therefore judged to be het- 
erokaryons (Fig.  5,  C and E;  Table  I).  Only some of the 
nuclei in heterokaryons were closely associated with FITC- 
labeled lysosomes (Fig. 5 E). Those nuclei were considered 
to be of PtKl origin, while the remaining nuclei must have 
come  from CV-1 cells.  The heterokaryons typically con- 
tained approximately eight nuclei, the ratio of PtK1 to CV-1 
nuclei ranged from 1:8 to 4:1, and an average of 33% of the 
nuclei within each syncytium were derived from PtK~ cells 
(Table I). 
The Effects of  BFA in Heterokaryons 
Immunofluorescence microscopy of permeabilized cells was 
used to examine Golgi complexes in syncytia in the absence 
and presence of BFA at both short (30 rain) and long (I>1.5 h) 
intervals after fusion. BFA was used at 3.6 and 36 gM (1 and 
10 gg/ml) throughout this series of experiments. Results at 
the two concentrations were indistinguishable from one an- 
other, though only those obtained using the higher dosage 
are shown here (Figs.  6-8). 
At the early time points and in the absence of BFA, the 
nuclei within fused cells remained distant from one another, 
and staining with anti-58K indicated that each nucleus was 
in close proximity to its own distinct Golgi complex (data not 
shown). When BFA was present during the first 30 min after 
fusion, though, some of the nuclei in fused cells were situ- 
ated very close to a visible Golgi apparatus, while other nu- 
clei were not obviously associated with a Golgi complex. 
Syncytia containing both  types of nuclei were never ob- 
served in the absence of BFA, nor when PtKl or CV-1 cells 
alone were treated with low pH and BFA. 
As summarized in Table I, three considerations indicate 
that the BFA-resistant Golgi apparatuses and their associated 
nuclei  were  of PtK~ origin,  that  nuclei  which  lacked  a 
nearby Golgi apparatus were derived from CV-1 cells, and 
that fused cells which contained both types of nuclei were 
heterokaryons. First, the percentage of multinucleated cells 
that contained both types of nuclei (16%) was very similar 
to the proportion of multinucleated cells that were unambig- 
uously identified as heterokaryons by the FITC-labeled lyso- 
some method (20%; Fig. 5). Secondly, the range for the ratio 
of presumptive PtKl to CV-1 nuclei in apparent heterokary- 
ons,  as judged by immunofluorescence with anti-58K (1:8 
to 3:1),  was nearly identical to the range observed in un- 
equivocal heterokaryons using the fluorescent lysosome pro- 
cedure (1:8 to 4:1). Finally, on the average, ,,ol/3 of  the nuclei 
in heterokaryons labeled with FITC-dextran were close to 
fluorescent lysosomes, and, therefore, were of PtK~ origin. 
Likewise, staining of BFA-treated syncytia with anti-58K in- 
dicated that, on the average, ,,ol/3 of the nuclei were adjacent 
Ktistakis et al. The PtKI Cell Golgi ls Resistant to BrefeMin  .4  1015 Figure 5. Formation of heterokaryons by the fusion of CV-1 and PtK~ cells. Heterokaryons were formed by plating CV-1 cells that had been 
infected with an SV-40 strain containing the gene for VSV G protein onto monolayers of PtKt cells, and briefly exposing the mixed cell 
cultures to pH 5.5. The PtKl cells in this case had been labeled earlier with FITC-dextran, which entered the cells by fluid-phase endocy- 
tosis and eventually  accumulated in lysosomes. VSV G protein located on the plasma membrane was detected by staining fixed, unpermeabi- 
lized cells with rabbit polyclonal  anti-VSV G protein followed by TRITC-labeled goat anti-rabbit  IgG. Corresponding phase contrast (trans- 
mined light) and fluorescein and rhodamine epifluorescence images are shown. Appreciable cell fusion occurred only when the acid wash 
was included (.4, C, and E). When the acid wash was omitted, multinucleated cells were not observed (B, D, and F). Bar,  10 ~m. 
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Method for identifying 
heterokaryons 
Percent syncytia identified as heterokaryons  in: 
PtK~ and CV-I  PtK~ and CV-I  CV-I cells 
co-cultores  co-cultures  plated alone 
plus low pH  minus low pH  plus low pH 
tre~tm,-~  treatment  treatment 
Syncytia labeled with  20 (n  =  60)  1.7 (n  =  60)  ND 
FITC-dextran and 
anti-VSV G  protein  *7.8  +  1.6 
(see Fig.  5)  133  -1- 26% 
Jl:8 to 4:1 
Syncytia with BFA-resislant  16 (n  =  160)  2.5  (n  =  80)  0  (n  =  80) 
Golgi complexes 
30 rain after fusion  *7.5 + 2.0 
(see Fig. 6)  130 +  19% 
§1:8 to 3:1 
Syncytia with BFA-resistant  22 (n =  100)  1 (n =  80)  0 (n =  80) 
merged Golgi complexes 
3.5 h after fusion 
(see Fig. 7) 
* Mean number of nuclei per ~  +  the SD. 
~: Mean percentage of nuclei of PtK~ origim 5: the SD (klenlifiod by proximity to FITC-labeled  lysosomes or BFA-rusistant  Golgi complexes). 
§ Range  for the ratio of PtlKi to CV-I nuclei. 
to  a  58K-positive Golgi appmatus in cells that contained 
fewer Golgi complexes than nuclei. It is reasonable to con- 
clude, therefore, that heterokaryons corresponded to those 
syncytia that  contained both  BFA-resistant and  sensitive 
Golgi complexes, which originated in PtKm and CV-1 cells, 
respectively. 
As illustrated in Fig. 6, most detectable Golgi complexes 
in heterokaryons were stained not only by anti-58K, but by 
anti-VSV G protein, as well. Staining by the latter antibody 
indicated that VSV G protein, which was provided to the het- 
erokaryons by CV-1 cells, was able to enter Golgi complexes 
supplied to the syncytia by PtKt cells within 30 rain after 
cell fusion. There has been a prior report of  heterologous ER 
to Golgi transport in heterokaryons within this time frame, 
although homologous transport can be detected much earlier 
(Valtersson  et al.,  1990).  It is also worth noting that while 
cells in Figs. 5 and 6 were stained with anti-VSV G protein, 
labeled  Golgi complexes can be  found only in the latter 
figure. This is because the cells in Fig. 6, but not those in 
Fig. 5, were permeabilized before being stained with the an- 
tibody to VSV  G protein. 
To examine the effects of BFA at a later time point, cells 
were fused, incubated for 3 h in normal pH media, and then 
exposed to BFA for 30 min. Immunofluorescence staining of 
these cultures with anti-58K and anti-VSV G protein revealed 
the presence of numerous syncytia characterized by one or 
two centrally located clusters of nuclei, each group of which 
was associated with a large, intact Golgi apparatus that was 
labeled by both antibodies (Fig. 7, A-D). Syncytia like these 
represented 22 % of the multinucleated cells, a value consis- 
tent with their identification  as heterokaryons (Table I). Mul- 
tinucleated cells with these properties were also seen when 
the BFA incubation step was omitted, but were never ob- 
served in BFA-treated polykaryons formed by fusing virally 
infected CV-1 cells to uninfected monolayers of the same cell 
type (Table I). Evidently, therefore, the process of cell fusion 
itself does not induce the resultant syncytia to be resistant 
to BFA. 
The merged Golgi complexes present in heterokaryons 
that had been treated with BFA beginning 3 h after fusion 
clearly exhibited the BFA-resistant phenotype of the PtK~ 
cells. An important point that remained to be clarified, though, 
was whether or not these same Golgi complexes also con- 
tained components derived from CV-1 cells. To address this 
issue, we used a polyclonal antibody that was made against 
human milk Gal T, and stains the Golgi complexes by immu- 
nofluorescence in CV-1, but not PtK~ cells (Fig.  8, A and 
B). Cultures that had been allowed to recover in normal pH 
medium for 1.5 h  after fusion and were then treated with 
36 #M (10/zg/ml) BFA for an additional 30 min were stained 
for double immtmofluorescence with anti-Gal T and a mAb 
specific for VSV G protein. As shown in C and D of Fig. 8, 
the Golgi elements defined in these syncytia by anti-VSV G 
protein were also prominently labeled by the antibody to 
Gal 1". Identical staining patterns were observed in compara- 
ble cultures that had not been treated with BFA, indicating 
that incorporation of the CV-1 form of Gal T into the merged 
Golgi complex was not an adventitious result of exposure to 
the drug (data not shown). 
Several conclusions are warranted based on the results ob- 
tained with the fused cells. It seems clear that the BFA-re- 
sistant, Gal T-positive Golgi complexes found in cells >/1.5 h 
after fusion represented a merger of Golgi components de- 
rived from both PtKl and CV-1 cells. Within such merged 
Golgi  complexes,  the  PtK~ phenotype of BFA  resistance 
was dominant over the CV-1 cell phenotype of BFA sensitiv- 
ity. 30 min after fusion, though, when the Golgi complexes 
in syncytia were still separate, heterokaryons contained both 
BFA-resistant and -sensitive Golgi apparatuses. These col- 
lective observations are not compatible with models stipulat- 
ing that PtK~ cells are unable to accumulate pharmacologi- 
cally active BFA, or contain a cytosolic factor which abrogates 
the effects of the drug. Instead, the data indicate that PtK~ 
cells contain a nondiffusible factor which is tightly associated 
with the Golgi complex or a nearby compartment, and which 
confers resistance to BFA. 
Ktistakis  et al.  The PtK1 Cell Golgi Is Resistant to Brefeldin A  1017 Figure 6. Individual heterokaryons contain both BFA-resistant and -sensitive Golgi complexes 30 min after cell fusion. Heterokaryons were 
generated as in Fig. 5, and the cultures were maintained in the presence of 36/~M  (10/zg/ml) BFA for the next 30 min. The cells were 
then fixed, permeabilized, and stained for double immunofluorescence using mouse monoclonal anti-58K and rabbit polyclonal anti-VSV G 
protein followed by Texas red-labeled  goat anti-mouse IgG and FITC-labeled goat anti-rabbit IgG. Shown here are corresponding FITC 
(A, C, and E) and Texas red (B, D, and F) micrographs of three syncytia in which some, but not all nuclei were associated with a BFA- 
resistant Golgi complex. Multinucleated cells such as these were beterokaryons, the nuclei close to BFA-resistant Golgi complexes (arrow- 
heads) were of PtK~ origin,  and the nuclei that lacked an associated Golgi complex were derived from CV-I cells.  Bar, 10/zm. 
BFA Effects in Perforated Cell Models 
A limitation of the experiments with heterokaryons was that 
the ratio of resistant to sensitive cell components could be 
varied to only a small extent. Thus, it was of interest to inves- 
tigate the resistance of PtK~ cells to BFA in a system where 
sensitive or resistant cytosolic components could be present 
in great excess. This is possible with perforated cells, an ap- 
proach that has been used successfully to reconstitute trans- 
port from the ER to Golgi complexes (Beckers et al.,  1987; 
Beckers and Balch,  1989; Simons and Verta,  1987), export 
from the Golgi complexes (Bennett et al.,  1988) and several 
steps of endocytosis (Smythe et al., 1989; Podbilowicz et al., 
1990). 
In  the  present  case,  PtKt  cells  and  two  BFA-sensitive 
monkey kidney lines,  CV-1, and  MA104,  were perforated 
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tain large, merged, BFA-resis- 
tant Golgi complexes 3 h after 
fusion.  Heterokaryons  were 
generated as in Fig. 5 and 6 
and incubated with 36 #M (10 
#g/ml) BFA for 30 min begin- 
ning 3 h after fusion. The ceils 
were  then fixed,  perrneabilized, 
and stained for double immu- 
nofluorescence  using mouse 
monoclonal anti-58K and rab- 
bit polyclonal anti-VSV  G pro- 
tein followed  by Texas red-la- 
beled  goat  anti-mouse  IgG 
and FITC-labeled goat  anti- 
rabbit  IgG. Shown here are 
corresponding FITC (A and C) 
and Texas  red (B  and D) micro- 
graphs  of two heterokaryons 
which contained merged, BFA- 
resistant  Golgi  complexes. 
Bar, 10 #m. 
using nitrocellulose membranes. MA104 ceils were observed 
to behave identically to CV-1 cells in all of the fusion experi- 
ments previously described (data not shown), but were supe- 
rior to the CV-1 cells for the perforation experiments because 
they adhered to the coverslips more tightly. The perforated 
cells were found to be readily permeable to macromolecules, 
such as IgG, because cytoplasmic antigens could be stained 
by  immunofluorescence methods  following  fixation  with 
formaldehyde, without the need for additional permeabiliza- 
tion steps.  Parallel cultures of unperforated cells remained 
completely unstained when processed in an otherwise identi- 
cal manner (data not shown). The standard design of these 
experiments was  to  perforate cells,  incubate them  in  the 
presence or absence of BFA for 30 min, and then fiX. Fol- 
lowing fixation, the cell models were stained for immunoflu- 
orescence using the monoclonal antibody to/S-COP. This an- 
tibody was chosen because removal of/S-COP from Golgi 
membranes can be detected in cells sensitive to BFA less 
than 1 min after their initial exposure to the drug (Donaldson 
et al.,  1990). This phenomenon is the earliest known effect 
of BFA, and we reasoned, therefore, that it might be one of 
the easiest BFA-dependent events to duplicate in a cell model 
system. A very similar approach was used recently to impli- 
cate a GTP-15inding protein in maintaining the association of 
~COP with the Golgi membranes in perforated cells (Donald- 
son et al.,  1991). 
When MA104 or PtK1 cells were perforated and then in- 
cubated with either buffer plus cytosol, or buffer plus ATP 
and GTP, immunofluorescent staining of/S-COP was notice- 
ably less intense than in intact cells (data not shown). When 
the incubation solution was composed of cytosol and ATP 
plus GTP, though, staining of/~-COP was indistinguishable 
from that observed in intact cells (Fig. 9, A and B). Appar- 
ently, nucleoside triphosphate(s), and one or more cytosolic 
factors are required to stabilize/S-COP on the Golgi mem- 
branes, so cytosol and both nucleotides were used for all sub- 
sequent experiments. 
As illustrated in C and D of Fig. 9, BFA was able to drive 
/S-COP off  of the Golgi apparatus in perforated MA104 cells 
incubated with  MA104 cytosol, but not in  the perforated 
PtKl cells treated with PtKt cytosol. When perforated cells 
of each type were incubated with the heterologous cytosol 
and BFA, the response to BFA was determined by the cell 
model, not the cytosol. MA104 cell cytosol did not allow 
/S-COP in the perforated PtK~ cells to be removed from the 
Golgi apparatus  by BFA,  nor did  PtK~ cytosol cause  the 
perforated MA104 cells to become resistant to BFA (Fig. 9, 
E and F). Taken together, observations of both heterokaryons 
and perforated cells indicate that the resistance of PtK1 cells 
to BFA is probably because of a nondiffusible factor which 
is located on or very near the Golgi apparatus, and appears 
to be unique to this cell line. 
Discussion 
In the course of examining the effects of BFA  on 58K,  a 
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resistant Golgi  complexes  pres- 
ent in heterokaryons 2 h after 
fusion contain the CV-I form 
of galactosyltransferase (GAL 
T).  Unfused  CV-1 (A)  and 
PtKt  (B)  cells  were  stained 
with  rabbit  polyclonal  anti- 
Gal T followed by TRITC-Ia- 
beled  goat  anti-rabbit  IgG. 
Note that anti-Gal T  stained 
the  Golgi apparatus  in CV-I 
ceils, but PtKl cells were not 
immunoreactive. Heterokary- 
ons were generated as in Figs. 
5-7, and cultured in the pres- 
ence of  36 #M (10/~g/ml)  BFA 
for 30  min beginning  1.5  h 
after  fusion.  The cells were 
then fixed, permeabilized, and 
stained for double immunoflu- 
orescence using mouse mono- 
clonal anti-VSV G protein and 
rabbit polyclonal anti-Gal  T 
followed  by Texas red-labeled 
goat anti-mouse IgG (C) and 
FITC-labeled goat anti-rabbit 
IgG (D). Note that the merged 
Golgi complex exhibited the 
PtK~ phenotype of resistance 
to BFA,  and contained the CV-1 
form of Gal T. Bar, 10 ~m. 
Golgi-associated, microtubule-binding protein (Bloom and 
Brashear,  1989), we found that the Golgi complex in PtKz 
cells  was  not  disrupted  morphologically by the  drug,  as 
judged by immunofluorescence microscopy with anti-58K. 
Initially, we extended this basic observation in four principal 
directions.  First,  virtually identical results were obtained 
when  PtK1 cells  were  exposed to  BFA  concentrations  at 
least 100-fold greater than that required for complete disso- 
lution of the Golgi apparatus  in  sensitive cells.  Secondly, 
similar results were obtained using two additiona! antibod- 
ies,  one directed against another Golgi-associated protein, 
~COP (ll0-kD protein; Alan and Kreis, 1986; Duden et al., 
1991;  Serafini et al.,  1991),  and the other specific for the 
VSV G protein. Next, fluorescence microscopy of PtK1 cells 
treated with the vital Golgi stain, Ct-NBD-ceramide, dem- 
onstrated once again that the Golgi apparatus in this cell line 
remains intact in the presence of  high concentrations of  BFA. 
Finally, we found that in PtK1 cells BFA did not inhibit two 
major Golgi-dependent activities, secretion, and conversion 
of newly synthesized glycoprotein from high  mannose to 
complex carbohydrate forms. Taken together, these observa- 
tions indicated that both morphological and functional prop- 
erties of the Golgi complex are resistant to BFA in the PtK~ 
cell line. 
The possible mechanisms of this resistance to BFA can be 
sorted into two categories, one of which is potentially impor- 
tam  for investigations of Golgi function and the other of 
which is inconsequential in that regard. In the latter group 
are the common mechanisms by which cells prevent the con- 
centration of a drug from reaching levels sufficient to cause 
its usual effects. These include failing to import the drug, or 
actively exporting, sequestering, inactivating, or degrading 
it. In the former group are mechanisms that involve a specific 
molecular target of BFA or an immediate downstream effec- 
tot of that target, and could include the alteration or absence 
of either. 
Much of  the intense current interest in BFA stems from the 
assumption that this drug binds to a particular molecular tar- 
get on or near the Golgi apparatus,  and that this binding 
event results  in  the  inactivation of a  single  Golgi-related 
function. It also has been proposed that the subsequent dra- 
matic effects of BFA depend upon the continued operation of 
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but not MA104 cells, are resis- 
tant to an early effect of BFA. 
Perforated cells were incubated 
in the presence of cytosol, ATP, 
and GTP with or without 36 gM 
(10  gg/ml)  BFA. They  were 
then  fixed,  and  stained  with 
mouse monoclonal anti-B-COP 
followed by Texas red-labeled 
goat anti-mouse IgG. Note that 
B-COP  remained  associated 
with the Golgi apparatus in per- 
forated  models  of  both  cell 
types. When BFA was present, 
though,  binding  of B-COP to 
the Golgi apparatus persisted in 
perforated PtK~, but not MA104 
cells,  regardless of which type 
of  cytosol was used. The arrows 
in B, D,  and F  indicate  Golgi 
complexes. Note also that vari- 
able levels of  staining on or near 
the nuclear envelope were rou- 
tinely observed in both cell types. 
Bar,  10/zm. 
otherwise normal processes, such as membrane recycling in- 
volving the ER and an intermediate compartment situated 
between the ER and Golgi apparatus (Lippincott-Schwartz et 
al.,  1990).  In  light  of these  hypotheses  about how  BFA 
works, demonstration of a "specifiC' resistance of BFA would 
provide important support for the critical assumption that a 
unique BFA target does, indeed, exist. In addition, the nature 
of this resistance might provide clues to the mechanism of 
action of the drug and the process by which the structural 
integrity of the Golgi complex is maintained. 
The PtK1 Phenotype of Resistance to BFA Is Dominant 
in Heterokaryons 
Two lines of experimentation were pursued in an effort to de- 
termine the basis for the  resistance of PtKt  cells to BFA. 
The first of these used the fusion of cells with a viral glyco- 
protein, an approach that has proven to be useful for studying 
inter-cisternal protein transport through the Golgi complex 
(Rothman et al.,  1984) and the fusion of Golgi membranes 
in newly formed syncytia (Ho et al.,  1990).  Heterokaryons 
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cells that had been infected with a recombinant virus which 
expressed the  VSV  G  protein.  After the  fusion  reaction, 
'°20 % of the multinucleate cells were determined to be het- 
erokaryons because they contained markers for both PtK~ 
and CV-1 cells. 
A hallmark feature of the cell fusion experiments is that 
multiple Golgi complexes originating from both PtKt and 
CV-1 cells were present within a common cytoplasm, and 
were physically separate from one another for at least 30 min 
after fusion had occurred. This allowed us to ask, in essence, 
a genetic question about such heterokaryons: in the presence 
of BFA, would the phenotype of  either cell type be dominant 
over the other or, during the period when the Golgi com- 
plexes remained separate, would each respond to the drug 
as it would have in an unfused cell? Each of the three poten- 
tial outcomes would have indicated a unique set of possible 
mechanisms for the BFA resistance of PtK~ cells. In actual- 
ity, when syncytia were treated with BFA immediately after 
fusion,  each  Golgi complex behaved  independently as  it 
would have in an unfused cell. Approximately 20%  of the 
multinucleate cells contained both BFA-resistant and -sensi- 
tive Golgi complexes. Based on their frequency, it is likely 
that these cells represented the entire heterokaryon popula- 
tion (Table I), and it is noteworthy that we never observed 
syncytia in which all Golgi complexes were resistant to BFA. 
These results  indicate that the PtKI Golgi remains  intact 
even when it is in direct contact with biologically active lev- 
els of BFA, and virtually eliminate the possibility that PtK~ 
cells produce a diffusible, cytosolic factor which provides 
resistance to BFA. 
PtKl Cells Contain A Nondiffusible Factor That Confers 
Resistance to BFA 
When cultures were incubated for I>1.5 h after fusion, to al- 
low the nuclei within each syncytium to congregate near the 
cell center, one or two large, merged Golgi complexes were 
observed in all multinucleate cells.  22 %  of these merged 
Golgi apparatuses were both resistant to BFA and positive 
for the  CV-1 cell form of Gal T.  The frequency of cells 
exhibiting this  combination of phenotypic traits  indicated 
that they probably represented the heterokaryon population 
(Table I). 
The results of the cell fusion experiments cannot be ex- 
plained by the mere absence of a soluble BFA target in PtK~ 
cells. Such a target molecule should have been supplied in 
the heterokaryons by the parental CV-1 cells, and as a result, 
the PtK~ Golgi apparatuses in the early time point syncytia 
and the merged Golgi complexes found at later times should 
have been sensitive to BFA. No such observations were ever 
made, though. It might be argued that within the heterokary- 
on population, BFA-resistant Golgi complexes were present 
only in those rare syncytia which contained a large excess 
of PtK, nuclei over those of CV-1 origin. That explanation 
is inconsistent with the observations that "o20 % of multinu- 
cleated ceils, a proportion equal to that of the known hetero- 
karyons, exhibited BFA-resistant Golgi complexes, and that 
the average heterokaryon contained approximately eight nu- 
clei, of  which only two or three were of PtK~ origin (Table I). 
An alternative possibility is that PtKI cells are deficient 
in an insoluble BFA target,  in which case two likely out- 
comes could be imagined. First, if the target were bound to 
the Golgi or a closely associated structure in CV-1 cells, all 
fused Golgi complexes in heterokaryons 2 h or more after 
fusion should have been supplied with the target molecule 
and have been sensitive to BFA. Merged Golgi complexes 
that were resistant to BFA were observed in "o20% of the 
multinucleate cells at these late time points, though, elimi- 
nating this explanation from serious consideration. If cells 
other than PtKI contain a nondiffusible BFA target which is 
bound to a structure far removed from the Golgi complexes, 
a different outcome would have been expected for the cell fu- 
sion experiments. In that situation, the effects of BFA on the 
Golgi complexes would have to be indirect and involve a dif- 
fusible factor as an intermediate. As argued above, though, 
a diffusible factor cannot account for the results of the cell 
fusion experiments. 
The behavior of the heterokaryons is most simply explained 
by the presence of a PtKl-derived, nondiffusible  factor which 
confers resistance of the Golgi complex to BFA. This factor 
must be on or in direct apposition to the Golgi complex to 
account for the highly restricted locale in which it can exert 
its effects.  The existence in PtK1 cells of a factor exhibiting 
this narrow set of traits supports the hypothesis that BFA acts 
in other cell types through a specific target molecule located 
on or very close to the Golgi apparatus. Moreover, when this 
putative  target molecule and  the  PtKI  factor are  present 
within the common cytoplasm of a heterokaryon, the PtK~ 
factor dominates the response of the hybrid cell to BFA. 
A limitation of the studies with heterokaryons was that the 
relative proportion of cytoplasm or Golgi membranes de- 
rived from sensitive or resistant cells could be varied only 
to a small degree. To circumvent this limitation, experiments 
were performed using cells in which the plasma membranes 
were perforated with nitrocellulose, an approach that has 
proven to be useful for studying a variety of steps in intracel- 
lular membrane traffic (Beckers et al.,  1987; Bennett et al., 
1988; Beckers and Balch,  1989; Simons and Verta,  1989; 
Smythe et al.,  1989; Podbilowicz and Mellman,  1990). In 
these experiments, as in another recent study conducted else- 
where (Donaldson et al., 1991), the focus was on the earliest 
known effect of BFA, the removal of/3-COP from the Golgi 
complex (Donaldson et al.,  1990). We found that the addi- 
tion of BFA to an incubation buffer containing ATP, GTP, 
and buffered autologous cytosol induced the release of/~-COP 
from the Golgi complex in perforated MA104 cells. This ef- 
fect was not prevented by replacing MA104 cytosol with a 
sizable excess of PtK~ cell cytosol, nor was B-COP driven 
from the Golgi complex by BFA in perforated PtKI cells 
that had been incubated with either PtK~ or MA104 cytosol. 
Since these experiments entailed the use of a large excess of 
cytosol isolated from a single source, it is evident that solu- 
ble,  cytosolic factors cannot make a  BFA-sensitive Golgi 
resistant to the drug, or convert a BFA-resistant Golgi to a 
drug-sensitive state. The perforated cell results thus support 
two fundamental conclusions of the fused cell studies: (a) a 
nondiffusible factor located on or very near the Golgi com- 
plex provides PtK~ cells with resistance to BFA;  and (b) a 
specific molecular target for BFA  is similarly localized in 
other types. 
What might be the nature of  the BFA resistance factor? One 
intriguing possibility is that it represents a BFA-insensitive, 
PtKt-specific form of the BFA target found in other mam- 
malian cell types. At the very least, it seems likely that this 
factor operates in a pathway downstream, but very close to 
The Journal of Cell Biology, Volume  113, 1991  1022 the target for BFA. In either case, the identification and char- 
acterization of the factor should help to clarify how BFA ex- 
erts its effects in the cell, and by extension, illuminate the 
molecular mechanisms responsible for maintaining the struc- 
tural and functional integrity of the Golgi apparatus. 
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